SCHEMBL25528343

SCHEMBL25528343

Cc1cnn(C)c1-c1ccc2c(c1)N(C)C(=O)[C@@H](C)N(Cc1cccc(C(=O)NCC3CCN(C)CC3)c1)C2=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.43
ROCK2 O75116 6/20 0.40
ROCK1 Q13464 3/20 0.40
BRD4 O60885 2/20 0.40
GLS O94925 2/20 0.40
MAP4K4 O95819 1/20 0.38
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
EGLN1 Q9GZT9 1/20 0.37
HDAC3 O15379 2/20 0.37
HDAC4 P56524 2/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC7 Q8WUI4 2/20 0.37
HDAC2 Q92769 2/20 0.37
HDAC10 Q969S8 2/20 0.37
HDAC11 Q96DB2 2/20 0.37
HDAC8 Q9BY41 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25528466 0.91 ROCK2 (0.37) PARP1ROCK2ROCK1BRD4GSK3B
SCHEMBL25528469 0.86 POLB (0.36) ROCK2ROCK1BRD4GSK3BMAPK14
SCHEMBL25529693 0.85 ROCK2 (0.51) PARP1ROCK2ROCK1
SCHEMBL25528346 0.84 ROCK2 (0.36) ROCK2ROCK1BRD4
SCHEMBL25528196 0.84 ROCK2 (0.43) PARP1ROCK2ROCK1BRD4GLS
SCHEMBL25528340 0.84 PARP1 (0.44) PARP1ROCK2ROCK1GLSMAP4K4
SCHEMBL25528762 0.83 CACNA1H (0.34) MAP4K4CDK1CCNB1CCNA2CDK2
SCHEMBL25528771 0.83 ROCK2 (0.42) PARP1ROCK2ROCK1BRD4HDAC3
SCHEMBL25528468 0.81 CACNA1H (0.36) MAPK14
SCHEMBL25528200 0.79 ROCK2 (0.40) PARP1ROCK2ROCK1MAP4K4HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023093787-A1 BENZODIAZEPINE COMPOUND AND APPLICATION THEREOF AS RHO KINASE INHIBITOR 成都奥睿药业有限公司 2023-06-01 WO disclosed